Qualigen Therapeutics (QLGN) shares soared about 200% on Monday at the peak after the biotech company secured a $41 million investment from Faraday Future (FFAI) and its founder YT Jia. Investors cheered QLGN also because it’s rebranding as CXC10 as part of a major pivot into crypto-Web3, revealing three growth engines: a crypto treasury, a DeAI trading platform, and ecosystem tokens. More News from Barchart QLGN stock has since reversed much of the post-announcement gains, but is still trading up nearl ...